OS-SiA

by OptraSCAN  · Based in United States → — See every cell.Trust every diagnosis.
Laboratory Medicine Oncology Pathology

Paid
Regulatory Status Disclosed

Overview

OS-SiA by OptraSCAN is a patented technology that enables simultaneous scanning, indexing, and analysis of whole-slide images. It is designed for modern pathology labs, research institutions, and telepathology networks.

  • What it does: OS-SiA powers AI-driven diagnostic analysis for various pathology applications, including histology, cytology, and bacteriology. It integrates with high-throughput whole-slide imaging scanners and enterprise image management software.
  • Who it is for: This technology is for pathologists and laboratory professionals in clinical labs, hospitals, and research settings. It supports specialties involved in cancer detection, grading, and biomarker analysis across different tissue types.
  • How it fits a clinical or practice workflow: OS-SiA allows AI analysis results to be available immediately after scanning is complete, streamlining the workflow by eliminating a separate analysis step. It supports automated cell detection, IHC and biomarker scoring (e.g., HER2, ER, PR, Ki-67), and cancer classification for prostate, breast, GI, and lung tissue.
  • Notable capabilities: OS-SiA is the core technology behind specialized AI solutions like HistoSiA for quantitative IHC analysis in breast cancer, CytoSiA for cervical cancer screening with Bethesda-standardized triage, and BactoSiA for AI-assisted tuberculosis detection and AFB grading. It features a foundation model architecture for multi-organ expansion and offers reproducible scoring validated across institutions and scanners.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Whole-Slide Imaging Scanners
  • AI-Powered Diagnostic Analysis
  • Enterprise Image Management
  • Automated cell detection
  • IHC & biomarker scoring
  • Grading & cancer classification
  • Foundation model architecture
  • Simultaneous Scan u00b7 Index u00b7 Analyze technology (OS-SiAu2122)

Use Cases

  • Breast Cancer IHC Biomarker Analysis
  • Cervical Cancer Screening
  • TB Detection & AFB Grading
  • Cancer detection, grading, IHC quantification, and biomarker discovery
  • Telepathology networks
  • Research institutions

What Physicians Need to Know

Whole Slide Image Support
OS-SiA™ powers the simultaneous scan, index, and analysis of whole slide images, providing AI results as soon as scanning finishes.
Digital Pathology Integration
OS-SiA™ is the core technology behind OptraSCAN's integrated platform, which includes high-throughput scanners and enterprise image management for end-to-end digital pathology workflows.
Stain Compatibility
Supports quantitative IHC analysis for various biomarkers including HER2, ER, PR, Ki-67, AE1/3, EGFR, and p53.
Biomarker Detection Capabilities
Provides quantitative IHC analysis for HER2, ER, PR, Ki-67, AE1/3, EGFR, and p53, with automated ASCO-CAP scoring and auto-segregation into diagnostic categories.
Turnaround Time Impact
AI results are available as soon as scanning finishes due to simultaneous scan, index, and analyze technology. For bacteriology, it offers 2–4 minute slide-to-report.
CAP/CLIA Compliance
Offers automated ASCO-CAP scoring for breast cancer IHC biomarker analysis.
Supported Cancer Types
Supports breast cancer (IHC biomarker analysis), cervical cancer (screening), lung cancer, and prostate cancer (grading and classification).
Quantitative Analysis Features
Automated cell detection (tumor foci, mitotic figures, immune infiltrates), reproducible IHC & biomarker scoring, and outcome-linked grading for various tissue types.
Physician Tip

OS-SiA's simultaneous scan, index, and analyze technology provides immediate AI results post-scan, significantly reducing turnaround time. Its validated deep learning models offer reproducible IHC scoring and automated grading, which can enhance diagnostic consistency and efficiency for breast, cervical, lung, and prostate cancer cases. The platform's ability to auto-segregate into diagnostic categories and provide clinician-ready results can streamline workflows.

OS-SiA™ powers OptraSCAN's end-to-end platform, integrating with OptraSCAN's whole-slide imaging scanners (OS-SiX, OS-Lite, OS-Ultra, OS-FLi) and enterprise image management software. This creates a unified system for image acquisition, AI-powered analysis, and secure image storage/sharing.

Details

Category Pathology AI
Pricing Paid
DeploymentCloud-ready
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Laboratory Medicine, Oncology, Pathology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate OS-SiA

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for OS-SiA.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

OS-SiA is OptraSCAN's patented technology that simultaneously scans and analyzes a slide. This integration means AI results are available immediately after scanning, eliminating a separate analysis step.
OS-SiA powers specialized AI platforms like HistoSiA for histology, CytoSiA for cytology, and BactoSiA for bacteriology, catering to specific diagnostic challenges in these fields.
For histology, OS-SiA enables quantitative IHC analysis for biomarkers such as HER2, ER, PR, Ki-67, AE1/3, EGFR, and p53, including automated ASCO-CAP scoring.
For cytology, OS-SiA provides AI-powered cervical cancer screening, offering Bethesda-standardized triage and automated reporting for classifications like HSIL, LSIL, and ASCUS.
For bacteriology, OS-SiA assists in tuberculosis detection and AFB grading with high accuracy, providing WHO-standardized bacillary grading.
In North America, the OptraSCAN System, including OS-ULTRA and HER2 IHC, is for diagnostic use, while other OS-SiA powered products are for research use only.

Related Tools

PathologyAILab
PathologyAILab
Lab & Diagnostics
PathologyAILab provides AI-enhanced digital pathology analysis and diagnostic insights for healthcare providers, utilizing a multi-agent AI system for faster, more accurate cytology results.
ArteraAI Breast
Artera
Clinical Decision Support & Reference
ArteraAI Breast is an AI-powered digital pathology tool that helps physicians assess the risk of distant metastasis in patients with early-stage HR+/HER2- breast cancer, aiding in personalized treatment decisions.
Indica Labs HALO AI
Indica Labs
Drug Discovery & Research
HALO AI is a deep-learning add-on for the HALO image analysis platform, helping users solve image analysis challenges in segmentation, classification, and phenotyping for research.
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI
Clinical Decision Support & Reference
The Claire OCT System by Perimeter Medical Imaging AI uses Optical Coherence Tomography and AI to provide real-time, high-resolution tissue imaging during surgery to help identify cancerous tissue.
SOPHiA DDM
SOPHiA GENETICS
Oncology AI
SOPHiA DDM™ is an AI-driven and cloud-powered platform that helps clinicians generate real-time, actionable insights for patients with cancer and rare disorders by analyzing complex genomic, radiomic, and multimodal data.
DeepBio DeepDx® Prostate
DeepBio
Oncology AI
DeepDx® Prostate leverages deep learning to standardize prostate cancer diagnostics by detecting abnormalities in digital slides with high precision, providing automated Gleason grading, tumor quantification, and tumor length measurements.

See all Pathology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-11-08
AI Tool Finder
AI-powered search. Results may not be comprehensive.